Skip to main content
Premium Trial:

Request an Annual Quote

Genomatix, USU Seek to Use NGS to Find Prostate Cancer Prognostic Markers

Premium

Genomatix Software, the Uniformed Service University of the Health Sciences, and the Henry M. Jackson Foundation for the Advancement of Military Medicine will collaborate on a project to use next-gen sequencing to help identify biomarkers for prostate cancer prognostics.

The goal of the collaboration is to identify biomarkers that can be used to help predict the outcome of prostate cancer patients at the time of diagnosis, which is currently difficult to do.

The project will combine USUHS' Center for Prostate Diseases Research's translational research resources and expertise with Genomatix's data-analysis software to identify novel androgen receptor-binding sites to analyze prostate cancer metastasis using model systems and clinical specimens.

"Next-generation sequencing opens a new dimension in biomarker research and will allow a finer grained, unbiased look at some of the genomic mechanisms behind prostate disease, thus providing the opportunity for the discovery of new prognostic biomarkers, some of which also may be targets for therapeutic intervention and treatment monitoring," Genomatix founder Thomas Werner said in statement.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.